13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
35 檔
47.2%
During the Q2 2024 filing period, Knoll Capital Management, LLC (CIK: 0001325083) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $179.3M across 35 reported positions.
In Q2 2024, Knoll Capital Management, LLC displayed an active expansion posture, initiating 1 new positions and adding to 2 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | APLT | Applied Therapeutics Inc | Stock-Other | 17.54% | — | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 16.62% | -10.93% | +44.86% | |
| 3 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 12.21% | +1.36% | — | |
| 4 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 5.68% | — | — | |
| 5 | ALT | Altimmune Inc | Stock-Other | 5.03% | — | +97.72% | |
| 6 | ✓ | Entera Bio LTD | Stock-Other | 4.81% | +2.22% | — | |
| 7 | GLD | Spdr Gold Shares | ETF-Commodities | 4.64% | — | — | |
| 8 | SIL1EUR | Silvercrest Metals Inc | Stock-Other | 2.58% | — | — | |
| 9 | KGC | Kinross Gold CORP | Stock-Materials | 2.47% | -1.20% | — | |
| 10 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 2.45% | -1.38% | — | |
| 11 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 2.27% | -0.44% | — | |
| 12 | ✓ | Hookipa Pharma | Stock-Other | 2.20% | — | — | |
| 13 | MQ8 | Mag Silver CORP | Stock-Other | 2.16% | — | — | |
| 14 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 2.12% | -0.13% | — | |
| 15 | FNV | Franco-nevada CORP | Stock-Materials | 2.00% | -0.67% | — | |
| 16 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 1.95% | — | — | |
| 17 | EQX | Equinox Gold CORP | Stock-Other | 1.94% | — | — | |
| 18 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 1.35% | +2.62% | — | |
| 19 | SIL | Global X Silver Miners ETF | ETF-Commodities | 0.95% | — | — | |
| 20 | OCUL | Ocular Therapeutix Inc | Stock-Other | 0.92% | +3.48% | — | |
| 21 | SLV | Ishares Silver Trust | ETF-Commodities | 0.87% | — | — | |
| 22 | V | Visa Inc-class A Shares | Stock-Financials | 0.86% | — | — | |
| 23 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.85% | -0.38% | — | |
| 24 | PM | Philip Morris International | Stock-Consumer Staples | 0.68% | +0.09% | — | |
| 25 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.68% | +0.10% | — | |
| 26 | RGLD | Royal Gold Inc | Stock-Materials | 0.64% | -1.58% | — | |
| 27 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.64% | -0.20% | — | |
| 28 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.63% | — | — | |
| 29 | CVS | Cvs Health CORP | Stock-Healthcare | 0.58% | — | — | |
| 30 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.57% | — | — | |
| 31 | NEWP | New Pacific Metals CORP | Stock-Other | 0.49% | -0.02% | — | |
| 32 | ✓ | Orgenesis, Inc. | Stock-Other | 0.26% | -0.01% | — | |
| 33 | SKE | Skeena Resources LTD | Stock-Other | 0.14% | — | — | |
| 34 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.14% | -0.07% | EXIT | |
| 35 | IRD | Opus Genetics Inc | Stock-Other | 0.10% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALT | Altimmune Inc | +1.4% | +97.72% | Add |
| 2 | ALDX | Aldeyra Therapeutics Inc | +1.1% | — | Unchanged |
| 3 | KGC | Kinross Gold CORP | +0.8% | — | Unchanged |
| 4 | ✓ | Entera Bio LTD | +0.8% | — | Unchanged |
| 5 | SIL1EUR | Silvercrest Metals Inc | +0.6% | — | Unchanged |
| 6 | GLD | Spdr Gold Shares | +0.5% | — | Unchanged |
| 7 | AEM | Agnico Eagle Mines LTD | +0.4% | — | Unchanged |
| 8 | WPM | Wheaton Precious Metals CORP | +0.4% | — | Unchanged |
| 9 | MQ8 | Mag Silver CORP | +0.4% | — | Unchanged |
| 10 | SLV | Ishares Silver Trust | +0.2% | — | Unchanged |
| 11 | SIL | Global X Silver Miners ETF | +0.2% | — | Unchanged |
| 12 | BAH | Booz Allen Hamilton Holdings | +0.2% | — | Unchanged |
| 13 | FNV | Franco-nevada CORP | +0.2% | — | Unchanged |
| 14 | CRDL | Cardiol Therapeutics Inc-a | +0.1% | NEW | New buy |
| 15 | AGI | Alamos Gold Inc-class A | +0.1% | — | Unchanged |
| 16 | PM | Philip Morris International | +0.1% | — | Unchanged |
| 17 | MREO | Mereo Biopharma Group Pl-adr | +0.1% | — | Unchanged |
| 18 | NEWP | New Pacific Metals CORP | +0.1% | — | Unchanged |
| 19 | RGLD | Royal Gold Inc | +0.1% | — | Unchanged |
| 20 | ITA | Ishares U.s. Aerospace & Def | +0.1% | — | Unchanged |
| 21 | SKE | Skeena Resources LTD | 0% | — | Unchanged |
| 22 | V | Visa Inc-class A Shares | 0% | — | Unchanged |
| 23 | NOC | Northrop Grumman CORP | — | — | Unchanged |
| 24 | IRD | Opus Genetics Inc | 0% | — | Unchanged |
| 25 | SEA1EUR | Seabridge Gold Inc | -0.1% | — | Unchanged |
| 26 | VRNA | Verona Pharma PLC - Adr | -0.1% | — | Unchanged |
| 27 | DEO | Diageo Plc-sponsored Adr | -0.1% | — | Unchanged |
| 28 | ✓ | Orgenesis, Inc. | -0.1% | — | Unchanged |
| 29 | BHVN | Biohaven Ltd. | -0.1% | +44.86% | Add |
| 30 | EQX | Equinox Gold CORP | -0.1% | — | Unchanged |
| 31 | CVS | Cvs Health CORP | -0.1% | — | Unchanged |
| 32 | OCUL | Ocular Therapeutix Inc | -0.2% | — | Unchanged |
| 33 | ✓ | Hookipa Pharma | -0.2% | — | Unchanged |
| 34 | ✓ | Avadel Pharmaceuticals PLC ADR | -0.6% | — | Unchanged |
| 35 | APLT | Applied Therapeutics Inc | -6% | — | Unchanged |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 35 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including APLT, BHVN, ALDX) accounted for 47.2% of total reported equity market value during Q2 2024.
Top New Position Initiated
CRDL
市值: $202.0K
During Q2 2024, Knoll Capital Management, LLC's top holdings by market value included APLT (17.5%)、BHVN (16.6%)、ALDX (12.2%). The largest single position, APLT, represented 17.5% of total portfolio value.
In Q2 2024, Knoll Capital Management, LLC made 3 total portfolio adjustments, initiating 1 new buys, adding to 2 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.